Yanyan Cen

774 citations
23 papers · 632 indexed · h-index 17
Topics
Immune Response and Inflammation (4 papers)Computational Drug Discovery Methods (2 papers)Glioma Diagnosis and Treatment (2 papers)
Partner nations
China

In The Last Decade

Yanyan Cen

23 papers receiving 625 citations

Peers

Yanyan Cen
Comparison fields: 5 of 88
  • Molecular Biology 241
  • Immunology 124
  • Epidemiology 75
  • Surgery 71
  • Pharmacology 61
Replace Xichun Pan with:
Xichun Pan China
Shan Su China
Labanyamoy Kole India
Seyed Saeed Seyedian Iran
Chung Hong Kong
Madhav Nilakanth Mugale India
Jufeng Xia Japan
Patrícia Burth Brazil
Maria Viskaduraki United Kingdom
Mohammad Tarique India
Yanyan Cen relative to Xichun Pan China Xichun Pan's profile →
Citations per field
00.5×1.5×
Xichun Pan · 1×
Citations per year

Countries citing papers authored by Yanyan Cen

Since Specialization
Citations

This map shows the geographic impact of Yanyan Cen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanyan Cen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanyan Cen more than expected).

Fields of papers citing papers by Yanyan Cen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanyan Cen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanyan Cen. The network helps show where Yanyan Cen may publish in the future.

Co-authorship network of co-authors of Yanyan Cen

This figure shows the co-authorship network connecting the top 25 collaborators of Yanyan Cen. A scholar is included among the top collaborators of Yanyan Cen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanyan Cen. Yanyan Cen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 12
3 7
4 31
5 33
6 36
7 24
8 59
9 21
10 7
11 26
12 33
13 36
14 17
15 16
16 20
17 33
18 43
19 62
20
Bama miniature pigs (Sus scrofa domestica) as a model for drug evaluation for humans: comparison of in vitro metabolism and in vivo pharmacokinetics of lovastatin.
41

About Yanyan Cen

Yanyan Cen is a scholar working on Molecular Medicine, Immunology and Microbiology, having authored 23 papers that have together received 632 indexed citations. Recurring topics across this work include Immune Response and Inflammation (4 papers), Computational Drug Discovery Methods (2 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Toxicology (26 citations), Pharmacology (61 citations) and Immunology (124 citations). Yanyan Cen has collaborated with scholars based in China. Frequent co-authors include Hong Zhou, Xichun Pan, Jiang Zheng, Rongxin Qin, Weiwei Jiang, Chao Liu, Bin Li, Xiaohong Chen, Tao Liu and Xueli Pang. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Applied Microbiology and Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026